<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR18">
 <label>18.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Cortes</surname>
    <given-names>JE</given-names>
   </name>
   <name>
    <surname>Heidel</surname>
    <given-names>FH</given-names>
   </name>
   <name>
    <surname>Heuser</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Fiedler</surname>
    <given-names>W</given-names>
   </name>
   <name>
    <surname>Smith</surname>
    <given-names>BD</given-names>
   </name>
   <name>
    <surname>Robak</surname>
    <given-names>T</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>A phase 2 randomized study of low dose ara-c with or without glasdegib (PF-04449913) in untreated patients with acute myeloid leukemia or high-risk myelodysplastic syndrome</article-title>
  <source>Blood</source>
  <year>2016</year>
  <volume>128</volume>
  <fpage>99</fpage>
 </element-citation>
</ref>
